iiinova — where your digital self keeps evolving

Reposted by Yara Abdou

MedPage Today @medpagetoday.com · 17/08/2026

"Clinically useful but imperfect." -- @yabdoumd.bsky.social, of the University of North Carolina, on PD-L1 expression in triple-negative breast cancer and the need for better biomarkers to guide care. www.medpagetoday.com/spotlight/tn...

medpagetoday.com

Despite Progress in TNBC, More Biomarkers Are Needed to Improve Outcomes

'PD-L1 is clinically useful but imperfect,' expert says

121

Reposted by Yara Abdou

OncLive @onclive.bsky.social · 08/05/2026

✨EXCLUSIVE PREVIEW📷: Ahead of #ASCO26, we spoke with breast cancer experts to see what HR+ & HER2+ research they're most looking forward to seeing. @yabdoumd.bsky.social @uicancercenter.bsky.social @erikahamilton9.bsky.social @ascocancer.bsky.social #bcsm #oncology www.onclive.com/view/asco-20...

001

Reposted by Yara Abdou

OncLive @onclive.bsky.social · 26/06/2025

Sign up for free to read our exclusive June web feature! 🔐 This feature explores the evolution of the HER2-positive #BreastCancer landscape, including data from the neoCARHP and CompassHER2 pCR trials. @ptarantinomd.bsky.social @jamouabbi.bsky.social @yabdoumd.bsky.social

111

Yara Abdou @yabdoumd.bsky.social · 11/05/2025

Today I graduate with my Master’s in Clinical Research. Grateful for the journey, the mentors who lifted me, the family who stood beside me, and the purpose that keeps me moving forward: advancing science that serves everyone #Onward @unclineberger.bsky.social @uncpublichealth.bsky.social

051

Yara Abdou @yabdoumd.bsky.social · 06/04/2025

Genomic assays have transformed BC care but they’re not the full story. Our review @JAMAOnc shows that racial gaps in outcomes persist, even after accounting for molecular features —urging a more holistic approach to precision medicine. @unclineberger.bsky.social jamanetwork.com/journals/jam...

011

Reposted by Yara Abdou

SWOG Cancer Research Network @swog.org · 27/01/2025

Analysis of RxPONDER trial data by @yabdoumd.bsky.social, et al, in JNCI highlights persistent racial disparities in #breastcancer outcomes. doi.org/10.1093/jnci... #bcsm #HealthDisparities @unclineberger.bsky.social @ibcresearch1.bsky.social @raalbany.bsky.social @jrgralow.bsky.social

083

Reposted by Yara Abdou

Ahmed Elkhanany @elkhanany.bsky.social · 12/12/2024

Hyping for my smart dear friend @yabdoumd.bsky.social from UNC, who is moderating Poster Spotlight Session 9: ctDNA Uses for Minimal Residual Disease Testing, Tumor Evolution, and Novel Technologies. Tomorrow at 7 AM at Stars at Night 3-4 #SABCS2024 #bcsm @sabcs.bsky.social

071